國藥(01099.HK)附屬國藥一致全年賺15.99億人民幣增長7.6%

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

國藥(01099.HK)附屬國藥一致全年賺15.99億人民幣增長7.6%

阿思達克 03-15 00:46

國藥控股(01099.HK)公布，附屬國藥一致(000028.SZ)2023年度業績快報，實現營業收入754.77億人民幣(下同)，按年增加2.8%。歸屬股東淨利潤15.99億元，增長7.6%，每股收益2.87元。

國藥控股(01099.HK)

Relevant Stocks

國藥控股(01099.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

國藥(01099.HK)附屬國藥一致全年賺15.99億人民幣增長7.6%

Services

About Us

Agreement Statement

Market News

國藥(01099.HK)附屬國藥一致全年賺15.99億人民幣 增長7.6%

Services

About Us

Agreement Statement

國藥(01099.HK)附屬國藥一致全年賺15.99億人民幣增長7.6%